James Engelhart
2017
In 2017, James Engelhart earned a total compensation of $2.5M as Chief Financial Officer at Biohaven Pharmaceutical Holding Co Ltd., a 420% increase compared to previous year.
Compensation breakdown
| Bonus | $178,500 |
|---|---|
| Option Awards | $1,991,700 |
| Salary | $327,003 |
| Other | $13,080 |
| Total | $2,510,283 |
Engelhart received $2M in option awards, accounting for 79% of the total pay in 2017.
Engelhart also received $178.5K in bonus, $327K in salary and $13.1K in other compensation.
Rankings
In 2017, James Engelhart's compensation ranked 4,402nd out of 14,666 executives tracked by ExecPay. In other words, Engelhart earned more than 70.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,402 out of 14,666 | 70th |
Division Manufacturing | 1,547 out of 5,770 | 73rd |
Major group Chemicals And Allied Products | 447 out of 2,074 | 78th |
Industry group Drugs | 343 out of 1,730 | 80th |
Industry Pharmaceutical Preparations | 271 out of 1,329 | 80th |
Source: SEC filing on March 29, 2018.
Engelhart's colleagues
We found two more compensation records of executives who worked with James Engelhart at Biohaven Pharmaceutical Holding Co Ltd. in 2017.